DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Dermatop (Prednicarbate Topical) - Summary

 
 



DERMATOP SUMMARY

DERMATOP Emollient Cream (prednicarbate emollient cream) 0.1% contains prednicarbate, a synthetic corticosteroid for topical dermatologic use. Topical corticosteroids constitute a class of primarily synthetic steroids used topically as anti-inflammatory and antipruritic agents. Each gram of DERMATOP Emollient Cream 0.1% contains 1.0 mg of prednicarbate.

DERMATOP Emollient Cream 0.1% is a medium-potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses. DERMATOP Emollient Cream 0.1% may be used with caution in pediatric patients 1 year of age or older. The safety and efficacy of drug use for longer than 3 weeks in this population have not been established. Since safety and efficacy of DERMATOP Emollient Cream 0.1% have not been established in pediatric patients below 1 year of age, its use in this age group is not recommended.
See all Dermatop indications & dosage >>

NEWS HIGHLIGHTS

Media Articles Related to Dermatop ( Topical)

Pilot program in pediatric long-term care facility halves topical antibiotic use
Source: Conferences News From Medical News Today [2015.06.26]
Requiring documentation of antibiotic indication improves overall usageA pilot antibiotic stewardship program at a pediatric long-term care facility brought about a 59 percent decrease in use of...

FDA Approves 1st Topical Gel to Ease Redness of Rosacea
Source: MedicineNet brimonidine Specialty [2013.08.28]
Title: FDA Approves 1st Topical Gel to Ease Redness of Rosacea
Category: Health News
Created: 8/27/2013 12:35:00 PM
Last Editorial Review: 8/28/2013 12:00:00 AM

Burn Risk Seen with Topical Pain Relievers
Source: MedPage Today Product Alert [2012.09.13]
WASHINGTON -- The FDA warned Thursday of the risks of rare but serious chemical burns with certain over-the-counter topical pain relievers, including Bengay, Capzasin, Flexall, Icy Hot, and Mentholatum.

Squalamine Shows Promise in Retinal Vein Occlusion
Source: Medscape Ophthalmology Headlines [2015.07.20]
The combination of topical squalamine and intravitreal ranibizumab appears to boost visual acuity more rapidly than ranibizumab alone in patients with retinal vein occlusion, a small study shows.
Medscape Medical News

New treatment for middle ear infection found in anti-stroke drug
Source: Ear, Nose and Throat News From Medical News Today [2015.05.22]
Animal study shows that topical use of the anti-stroke drug vinpocetine clears middle ear infection - suppressing inflammation and overproduction of mucus and restoring hearing.

more news >>

Published Studies Related to Dermatop ( Topical)

Effectiveness of topical curcumin for treatment of mastitis in breastfeeding women: a randomized, double-blind, placebo-controlled clinical trial. [2014]
inflammation in women suffering from lactational mastitis... CONCLUSION: The results of the current study indicate that topical preparation of

"Coffee plus honey" versus "topical steroid" in the treatment of chemotherapy-induced oral mucositis: a randomised controlled trial. [2014]
steroid, honey, honey plus coffee) in patients suffering from oral mucositis... CONCLUSION: Oral mucositis can be successfully treated by a combination of honey

Topical tetracaine used for 24 hours is safe and rated highly effective by patients for the treatment of pain caused by corneal abrasions: a double-blind, randomized clinical trial. [2014]
of pain caused by corneal abrasions... CONCLUSIONS: Topical tetracaine used for 24 hours is safe, and while there was no

Efficacy and safety of topical Trikatu preparation in, relieving mosquito bite reactions: a randomized controlled trial. [2014]
mosquito bite reactions... CONCLUSION: Trikatu did not show additional effects for relieving mosquito bite

A phase III randomized, placebo-controlled study of topical amitriptyline and ketamine for chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study of 462 cancer survivors. [2014]
efficacy of 2% ketamine plus 4% amitriptyline (KA) cream for reducing CIPN... CONCLUSIONS: This study suggests that KA cream does not decrease CIPN symptoms in

more studies >>

Clinical Trials Related to Dermatop ( Topical)

Standardized Time- and Score-Oriented Treatment of Moderate and Severe Atopic Dermatitis [Completed]
The study was designed to test the hypothesis whether a standardized, time-and score-oriented treatment following a strict evidence based algorithm is equally effective to a standard treatment regimen for moderate to severe atopic dermatitis.

Study Type: Mono-centre study, patients are blinded, physicians are randomized to either treat study- or controll group

Eligible are patients age 2 years or older with SCORAD >= 20 Duration: 12 Months, study visits every 4 weeks.

Primary endpoint is Difference between Baseline SCORAD and mean SCORAD under treatment.

Secundary endpoints are quality of life, safety and economic burden in both treatment groups.

Fexofenadine in Pruritic Skin Disease [Completed]

more trials >>


Page last updated: 2015-07-20

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015